LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SEQUENTIAL TREATMENT OF BRAF MUTANT ADVANCED MELANOMA PATIENTS

被引：0
|
作者：
Tarhini, Ahmad [1 ]
McDermott, David [2 ,3 ]
Ambavane, Apoorva [4 ]
Benedict, Agnes [4 ]
Lee, Cho-Han [5 ]
Ritchings, Corey [5 ]
Stwalley, Brian [5 ]
Regan, Meredith [2 ,6 ]
Atkins, Michael [7 ]
机构：
[1] Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Evidera, London, England
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页码：A130 / A131
页数：2
相关论文
共 50 条
  • [11] Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
    Long, Georgina, V
    Eroglu, Zeynep
    Infante, Jeffrey
    Patel, Sapna
    Daud, Adil
    Johnson, Douglas B.
    Gonzalez, Rene
    Kefford, Richard
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Sharfman, William
    McWilliams, Robert
    Sznol, Mario
    Redhu, Suman
    Gasal, Eduard
    Mookerjee, Bijoyesh
    Weber, Jeffrey
    Flaherty, Keith T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07) : 667 - +
  • [12] Long-Term Survival in Patients With Advanced Melanoma
    van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Jalving, Hilde
    Bloem, Manja
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot J. W. B., Jan Willem
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Leeneman, Brenda
    Piersma, D.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil G., Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [13] Long-term outcome of patients with advanced melanoma
    Parolin, V.
    Nortilli, R.
    Strina, C.
    Sabbioni, R.
    Sava, T.
    Cetto, G. L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 400 - 401
  • [14] Long-term effects of BRAF inhibitors in melanoma treatment: friend or foe?
    Sloot, Sarah
    Fedorenko, Inna V.
    Smalley, Keiran S. M.
    Gibney, Geoffrey T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (05) : 589 - 592
  • [15] Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
    Hauschild, Axel
    Ascierto, Paolo A.
    Schadendorf, Dirk
    Grob, Jean Jacques
    Ribas, Antoni
    Kiecker, Felix
    Dutriaux, Caroline
    Demidov, Lev V.
    Lebbe, Celeste
    Rutkowski, Piotr
    Blank, Christian U.
    Gutzmer, Ralf
    Millward, Michael
    Kefford, Richard
    Haas, Tomas
    D'Amelio, Anthony, Jr.
    Gasal, Eduard
    Mookerjee, Bijoyesh
    Chapman, Paul B.
    EUROPEAN JOURNAL OF CANCER, 2020, 125 : 114 - 120
  • [16] Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
    Wilmott, James S.
    Tawbi, Hussein
    Engh, Johnathan A.
    Amankulor, Nduka M.
    Shivalingam, Brindha
    Banerjee, Hiya
    Vergara, Ismael A.
    Lee, Hansol
    Johansson, Peter A.
    Ferguson, Peter M.
    Saiag, Philippe
    Robert, Caroline
    Grob, Jean -Jacques
    Butterfied, Lisa H.
    Scolyer, Richard A.
    Kirkwood, John M.
    V. Long, Georgina
    Davies, Michael A.
    CLINICAL CANCER RESEARCH, 2023, 29 (03) : 521 - 531
  • [17] Clinical outcomes in BRAFV600-mutant metastatic melanoma with sequential treatment with immunotherapy and BRAF inhibitors or vice versa.
    Aya, Francisco
    Fernandez, Aranzazu
    Victoria, Ivan
    Gaba, Lydia
    Pineda, Estela
    Arance, Ana M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [18] The Long-Term Results of Electrochemotherapy in the Treatment of Patients with Locoregionally Advanced, Unresectable Melanoma
    Zdzienicki, Marcin
    Zietek, Marcin
    Krotewicz, Maria
    Ewert-Krzemieniewska, Agnieszka
    Rutkowski, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [19] Outcomes following long-term response to immune checkpoint inhibitors in patients with advanced melanoma
    Handel, Eleanor
    McKeown, Janet
    Wei, Joe
    Kankaria, Roma
    Burnette, Hannah
    Lawless, Aleigha
    Czapla, Juliane
    Albrecht, Lea Jessica
    Mangana, Joanna
    Kessels, Jolien Isabel
    Allayous, Clara
    Boatwright, Christina Ann
    Ottaviano, Margaret
    Czarnecka, Anna Malgorzata
    Rutkowski, Piotr
    Lo, Serigne N.
    Long, Georgina V.
    Menzies, Alexander M.
    Carlino, Matteo S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [20] Primary Orbital Melanoma: Presentation, Treatment, and Long-term Outcomes for 13 Patients
    Rose, Anna M.
    Luthert, Philip J.
    Jayasena, Channa N.
    Verity, David H.
    Rose, Geoffrey E.
    FRONTIERS IN ONCOLOGY, 2017, 7
12345